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ABSTRACT. DNA is widely used to construct heterologously expressed genes. The adaptation of the 
codons to the host organism is necessary in order to ensure sufficient production of proteins. The GC 
content, codon identity and the mRNA from the translation site are also important in the design of the gene 
construct. This study performed a strategy for the design of synthetic gene encoding HPV52 L1 protein and 
several analyses at the genetic level to optimize its protein expression in the Escherichia coli BL21(DE3) 
host. The determination of the codon optimization was performed by collecting 75 HPV52 L1 protein 
sequences in the NCBI database. Furthermore, all the sequences were analyzed using multiple global 
alignments by Clustal Omega web server. Once the model was determined, codon optimization was 
performed using OPTIMIZER and the web server of the IDT codon optimization tool based on the E. coli 
B. The generated open reading frame (ORF) sequence was analyzed using Restriction mapper web server 
to choose the restriction site for facilitating the cloning stage, which is adjusted for pJExpress414 expression 
vector. To maximize the protein expression level, the mRNA secondary structure analysis around the 
ribosome binding site (rbs) was performed. A slight modification at the 5’-terminal end waa carried out in 
order to get more accessible rbs and increasing mRNA folding free energy. Finally, the construction of the 
synthetic gene was confirmed to ensure that no mutation occurs in the protein and to calculate its Codon 
Adaptation Index (CAI) and GC content. The above strategy, which leads to a good ORF sequence with 
the value of the free mRNA folding energy around rbs, is -5.5 kcal / mol, CAI = 0.787 and GC content 
49.5%. This result is much better than its original gene. This result is much better compared to its native 
gene. Theoretically it is possible that this synthetic gene construct generates a high level protein expression 
in E. coli BL21 (DE3) under the regulation of the T7 promoter. 
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INTRODUCTION 
Nowadays, synthetic DNA is widely used 
to construct the gene for heterologous protein 
expression. Adequate information from 
genome and metagenome sequencing projects 
provide virtual DNA, which can be further 
exploited. The modification of the native DNA 
sequences is mostly introduced into the 
synthetic gene to maximize the expression, 
especially in the heterologous host (Quan et al., 
2011; Gaspar et al., 2012; Luo et al., 2016). 
Several factors should be carefully considered 
when designing the construct, including codon 
usage, codon identity, GC-content, mRNA 
folding free energy, especially around the 
ribosome binding site (RBS). These play a role 
in the production of high-level recombinant 
proteins in Escherichia coli (Rosano & 
Ceccarelli, 2014; Ghavim et al., 2017; Dewi & 
Fuad, 2020). 
The final strategy for the design of 
synthetic gene is to mimic the characteristics of 
the natural highly-expressed gene of the native 
host that are relevant for increasing the protein 
expression.  Many researchers have reported 
that synonymous codons substitution of rare 
codons in the introduced genes can increase the 
protein yield dramatically (Chaney & Clark, 
2015; Wang et al., 2015; Buhr et al., 2016). 
Rare codons are associated with ribosome 
stalling leading to truncated translation (Handa 
et al., 2011; Guimaraes et al., 2020). In 
addition, synonymous codon changes can 
influence the protein stability and conformation 
(Saunders & Deane, 2010; Hunt et al., 2014; 
Mauro & Chappell, 2014). Therefore, codon 
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optimization plays an important role, mainly 
when the heterologous protein expression was 
performed. 
Human papillomavirus (HPV) is a non-
enveloped, double-stranded DNA virus that 
infects a variety of hosts, with a preference for 
epithelial cells. High-risk HPV infection is a 
major cause of cervical cancer development, 
which was the fourth most common cancer in 
women worldwide (Yang et al., 2017; Arbyn et 
al., 2020). The HPV L1 protein is the major 
capsid protein with a molecular weight of 55-
60 kDa that can be expressed in many 
expression systems and formed virus-like 
particles (VLP), which resemble the native 
HPV morphologically without the assistance of 
L2 minor capsid protein (Buck et al., 2013). 
VLPs are known to retain the native epitopes of 
viral particles. Their high immunogenicity can 
induce the production of neutralization 
antibodies against HPV infection (Schiller et 
al., 2010; Plummer & Manchester, 2011; 
Tumban et al., 2012). In addition, the VLPs are 
safe and have no potential cancerogenic to 
become the primary candidate for HPV 
vaccines because they do not contain the viral 
genome (Li et al., 2016; Huang et al., 2017). 
There are many online software packages 
available for performing codon optimization for 
designing the synthetic gene. EuGene (Gaspar 
et al., 2012), Parts & pools (Marchisio, 2014), 
Codon Optimization OnLine (COOL) (Chin et 
al., 2014), etc. are the newest software in the 
last 10 years. The previous software also still be 
used for gene design. In this study, the synthetic 
gene encoding HPV52 L1 protein was design 
for the development of an E. coli-based HPV 
vaccine. Not all available software was used, 
though it can be an alternative for designing 
other synthetic genes. In addition, the codon 
optimization and mRNA secondary structure 
formation near the translation initiation region 
become the primary concern. To the best of our 
knowledge, this study is the only one that 
discusses the codon optimization strategy and 
the construction of the synthetic gene encoding 




MATERIALS AND METHODS 
Determination of the HPV52 L1 protein 
sequence. About 75 sequences of HPV52 L1 
protein from various countries were collected 
from the National Centre for Biotechnology 
Information (NCBI) database 
(https://www.ncbi.nlm.nih.gov/). All the 
sequences were then subjected to multiple 
alignment analysis using Clustal Omega web 
server 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) 
(Sievers & Higgins, 2014). The HPV52 L1 
protein sequence having 100% identity 
discovered from this analysis was selected for a 
template in codon optimization step. 
Codon optimization for E. coli 
expression. The HPV52 L1 protein sequence 
was selected for codon optimization by using 
OPTIMIZER web server 
(http://genomes.urv.es/OPTIMIZER/) (Puigbò 
et al., 2007). Codon usage table of E. coli B 
used was used as a reference for accessing 
Kazusa codon usage database 
(http://www.kazusa.or.jp/codon/) (Nakamura 
et al., 2000). The “Guided random” method was 
selected for codon optimization. Generated 
codon-optimized sequence having a codon 
adaptation index (CAI) value near 0.8 and GC-
content near 51.06 % was chosen for further 
optimization. 
Selection of restriction site for 
facilitating the cloning stage. In this study, 
pJExpress414 plasmid with T7 promoter was 
selected as an expression vector for gene 
cloning. RestrictionMapper web server 
(http://www.restrictionmapper.org/) was used 
to determine the restriction sites located inside 
the codon-optimized gene. When the desired 
restriction sites were discovered, they were 
removed using the feature available in 
OPTIMIZER software (Puigbò et al., 2007). 
After the digesting enzymes were selected, then 
the expression cassette of 
pJExpress414_HPV52L1 recombinant plasmid 
was arranged. 
Determination of transcription start site 
(TSS). The first nucleotide of transcript (+1) 
was predicted using Neural Network Promoter 
Prediction 
(https://www.fruitfly.org/seq_tools/promoter.h
Vol 8(2), December 2020                                                                                             Biogenesis: Jurnal Ilmiah Biologi 227 
tml). About 115 nt before and 115 nt after the 
RBS was subjected to this analysis. The 
possible promoter sequence and +1 were 
selected based on the highest score. 
mRNA secondary structure analysis. 
The secondary structure formation of mRNA 
around the ribosome binding site was predicted 
using RNAstructure web server 
(https://rna.urmc.rochester.edu/RNAstructure
Web/Servers/Predict1/Predict1.html) 
(Bellaousov et al., 2013). The folding free 
energy of mRNA secondary structure was also 
observed. Synonymous codon substitution near 
the start codon was performed to increase the 
MFE of mRNA secondary structure. 
Confirmation of final synthetic gene 
construct. The final codon-optimized sequence 
was translated into proteins using ExPASy 
translate tools 
(https://web.expasy.org/translate/) (Gasteiger 
et al., 2003). Translated protein was subjected 
to pairwise sequence alignment analysis by 
Clustal Omega utilizing a template of the 
HPV52 L1 protein sequence as a tandem. If no 
mutation was confirmed, then the CAI value of 
the codon-optimized sequence was calculated 
using CAIcal (http://genomes.urv.es/CAIcal/E-
CAI/) (Puigbò et al., 2008). 
 
RESULTS AND DISCUSSION 
Determination of the HPV52 L1 protein 
sequence. In the determination of HPV52 L1 
amino acid sequence, about 75 samples were 
accessed from NCBI database and collected in 
Fasta format. Table 1 showed the accession 
number of HPV52 L1 protein sequence used in 
this experiment. To find the most promising L1 
protein sequence as a template, multiple 
sequence alignment analysis was performed 
using a Clustal Omega web server. The 
percentage identity matrix created by 
Clustal2.1 demonstrated that all sequences 
shared >99% identity (data are not shown). 
However, in this study, only the sequences that 
shared 100% identity were selected as a 
template for codon optimization. One is 
accession number APQ44871.1. 
 










South Korea APQ44863.1 USA AIF71419.1 North-western Guangdong AMN09991.1 
APQ44881.1 AIF71420.1 AMN09990.1 
APQ44864.1 AIF71421.1 Eastern Guangdong AFC35275.1 
APQ44865.1 AIF71423.1  AFC35272.1 
APQ44866.1 AIF71418.1 AFC35271.1 
APQ44867.1 AIF71417.1 AFC35256.1 
APQ44868.1 Croatia AIF71429.1 Southwest China AML81012.1 
APQ44870.1 AIF71425.1  AML80961.1 
APQ44871.1 AIF71428.1 AML80962.1 
APQ44872.1 AIF71427.1 AML80964.1 
Japan BBD06694.1 Hongkong AIF71404.1 AML80965.1 
BBD06686.1 AIF71403.1 AML80967.1 
BBD06702.1 AIF71401.1 AML80968.1 
BBD06678.1 AIF71400.1 AML80969.1 
BBA19957.1 AIF71399.1 AML80970.1 
BBA19973.1 AIF71397.1 UK AIF71434.1 
BBA19949.1 Canada ABU55796.1  AIF71410.1 
BBA19941.1 ABU55795.1 AIF71409.1 
BBA19933.1 ABU55794.1 AIF71408.1 
BBA19917.1. ABU55793.1 Zimbabwe AIF71435.1 
BBA19789.1 ABU55792.1 Iran QDH43417.1 
BBA19797.1 ABU55791.1 Mexico AIF71413.1 
BBA19773.1 ABU55790.1 Netherland CAA52590.1 
BBA19757.1 ABU55789.1 
BBA19741.1 Italy AIF71412.1 
AIF71411.1 
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A study conducted by Wei et al. (2018) 
showed that the elimination of several amino 
acids at the N-terminal of HPV52 L1 proteins 
improves their solubility in E. coli expression 
system without affecting their immunogenicity. 
Therefore, the codon optimization lies in amino 
acids number 15-503, which is counted from 
the second Methionine. Fig. 1 showed the 
amino acid sequence with Accession Number 
APQ44871.1. The amino acid sequence that 
was subjected to codon optimization was 












Fig. 1. Amino acids sequence of HPV52 L1 protein from accession number APQ44871.1. The yellow color indicates the 
codon-optimized region. 
 
Codon optimization for E. coli 
expression and selection of restriction site 
for facilitating the cloning stage. The codon 
optimization was carried out with the 
OPTIMIZER web server. Using the "Guided 
Random" method, codons were selected at 
random with probabilities obtained from the 
codon usage table of E. coli B. Generated 
codon-optimized sequence using this software 
gave the highest CAI value of 0.739 and GC-
content of 49.2% (Table 2).  
In this experiment, the pJExpress414 
plasmid was used as an expression vector. The 
SalI and NcoI restriction sites were selected at 
5’ and 3’ end to facilitate the cloning stage, 
respectively. However, by using the 
RestrictionMapper web server, it was reported 
that those restriction sites were inside the 
codon-optimized gene (data not shown). In 
addition, there were also repeated bases of A/T 
(Table 2). Therefore, both restriction sites and 
A/T repeated bases were removed using the 
feature discovered in OPTIMIZER web server.  
To increase the CAI and GC-content, the 
DNA sequence was further optimized manually 
using IDT codon optimization tool 
(https://sg.idtdna.com/CodonOpt). Table 2 
showed that the modified codon-optimized 
sequence has a higher CAI and GC-content, 
without SalI and NcoI restriction sites inside the 
gene. 
In this study, the codon optimization of 
HPV52 L1 open reading frame (ORF) was 
carried out using OPTIMIZER web server 
according to E. coli B codon usage table. 
Furthermore, the codon usage bias in a gene 
towards frequent codons is often measured by 
Codon Adaptation Index (CAI). CAI reflected 
how well our optimized-codon sequences will 
adapt to the new host protein expression 
machinery. The CAI value ranges from 0 to 1 
based on how close the foreign gene sequences 
against the reference gene sequences. However, 
the CAI value = 1 means “one amino acid – one 
codon” approach has several disadvantages, 
including translational error, tRNA depletion, 
frame-shift, hard to avoid repetitive elements, 
and hard to introduce or eliminate the 
restriction sites inside the ORF. Therefore, in 
this experiment wa “Guided random” method 
was used to optimize the gene instead of the 
“Most frequent” method provided by Puigbò et 
al. (2007), Welch et al. (2009), and Villalobos 
et al. (2016). The “Guided random” flexibility 
makes it easier to remove the desired restriction 
site and A/T repeated bases located inside the 
gene (Table 2).
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Table 2. The sequences of the codon-optimized gene using OPTIMIZER tool and its modification afterward. Green color 
indicates the SalI and NcoI restriction enzymes. Yellow color indicates the repeated A/T ≥ 6 bases.  
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Determination of transcription start site 
(TSS) and mRNA secondary structure 
analysis around the ribosome binding site. 
The pJExpress414 plasmid was used as an 
expression vector. The expression cassette of 
pJExpress414_HPV52L1 recombinant plasmid 
was arranged as seen in Fig. 2. The TSS was 
predicted using Neural Network Promoter 
Prediction web server. After the first nucleotide 
of transcript (+1) was determined, the mRNA 
sequence was subsequently decided, which will 
be subjected to secondary structure analysis 







Fig. 2. The expression cassette of pJExpress414_HPV52L1 recombinant plasmid. Red colour = T7 Promoter; magenta = 
lac operator; purple = ribosome binding site; blue = NcoI restriction site; black = L1 gene; orange = SalI restriction site; 
grey: T7 terminator. 
 
The sequence used for the analysis of the 
mRNA secondary structure started after codon 
start from +1 to seven amino acids (Table 3). 
The result showed that the original sequence 
has low mRNA folding free energy. In addition, 
the RBS sequence was shown in pairs with the 
downstream nucleotides (Fig. 3a). Therefore, 
the synonymous codon substitution was 
performed in order to increase the mRNA 
folding free energy and get unpaired RBS 
sequences. Fig. 3b showed that the mRNA 
folding free energy was increased from -7.3 to 
-5.5 kcal/mol and the RBS sequence was 
exposed after synonymous codon substitution 
was performed. Our previous experiment 
showed that mRNA folding free energy of -7.3 
kcal/mol in the area around the RBS was 
enough to produce high protein expression. 
Predicting the secondary structure of 
mRNA secondary is usually completed by 
finding the lowest folding free energy, which is 
the most likely folding ensemble structure 
(Reuter & Mathews, 2010). The increased 
folding free energy makes a more unstable 
mRNA secondary structure, which is preferred 
in E. coli expression. In addition, the open RBS 
makes it accessible for the ribosome to start the 
protein synthesis, which is expected to improve 
the expression of recombinant proteins in the E. 
coli system. 
 
Table 3. The mRNA sequences around the ribosome binding site used for mRNA used for the analysis of the secondary 
structure using RNAstructure web server. Transcription start (+1) is shown in a larger font, and blue color indicates the 
substituted codons. 




TGTTTAACTTTAGGAGGTAAAAAAAGTCGAC ATG CCA 
GTG CCG GTG TCT AAA GTT 
-7.3 
After synonymous codon 
substitution 
TGTTTAACTTTAGGAGGTAAAAAAAGTCGAC ATG CCA 


















Fig. 3. The mRNA secondary structure: a. before analysis; b. after analyzed by N-terminal synonymous codon substitution 
using RNAstructure web server.  
 
The expression of heterologous protein in 
E. coli was limited, especially at the initiation 
of translation. A strong mRNA downstream of 
the translation start site is known and can 
interfere with expression regardless of the 
general CAI or GC content (Gu et al., 2010; 
Gingold & Pilpel, 2011; Ghavim et al., 2017). 
Our previous study confirmed that the 
synonymous codon substitution immediately 
after the initial codon can significantly improve 
the expression of human granulocyte colony-
stimulating factor (hG-CSF) recombinant 





















Fig. 4. The final synthetic gene construction: a. translation result of the final synthetic gene construction using ExPASy 
translate tool; b. sequences alignment using Clustal Omega tool showed that no mutation has occurred in protein level 
except for the intentional N-terminal truncation. 
 
Confirmation of final synthetic gene 
construct. The final construction of the 
synthetic gene needs to be confirmed to ensure 
that no mutations occur at the amino acid level. 
The ExPASy translation tool was used to 
convert DNA sequences into protein sequences 
(Fig. 4a). The sequence alignment was 
performed using by Clustal omega using 
sequence with Accession Number APQ44871.1 
as a reference. Fig. 4b showed that no mutation 
occurred in the protein sequences except for the 
intentional N-terminal truncation. In the end, 
the final CAI was calculated using CAIcal web 
server, resulting in CAI = 0.787 with GC-
content 49.5%. This GC-content value is close 
to the required E. coli host (51.06%). The 
natural characteristic of the native HPV52 L1 
gene is low GC-content. The CAI of native 
HPV52 L1 gene from Accession Number 
KY077853 was calculated using CAIcal web 
b a 
b a 
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server with E. coli B codon usage table as a 
reference, and resulted in CAI = 0.616 with GC-
content 39.7%. Therefore, the synthetic gene 
construct showed good improvement of both 




The design of the synthetic gene encoding 
HPV52 L1 protein using the strategy above 
showed a good result with mRNA folding free 
energy around rbs of -5.5 kcal/mol, CAI = 
0.787 and GC-content 49.5%. This result is 
much better compared to its native HPV52 L1 
gene. Theoretically, thr obtained synthetic gene 
is prospective to produce high-level protein 
expression in E. coli BL21(DE3) under the 
regulation of T7 promoter. 
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